Detection and measurement of fetomaternal hemorrhage following diagnostic cordocentesis. 1998

Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
Service de Gynécologie Obstétrique, CHG Robert Ballanger, Aulnay-sous-Bois, France.

OBJECTIVE The aim of this study was to investigate the effect of cordocentesis on fetomaternal hemorrhage (FMH). METHODS One hundred and three diagnostic cordocenteses, without any other associated procedure, were performed at 23-40 weeks' gestation. FMH was detected using the Kleihauer-Betke staining of maternal blood taken immediately before and after cordocentesis. RESULTS Significant FMH occurred after 40 (38.8%) of the 103 procedures. An increased risk of fetal bleeding was associated with both an anterior placenta (odds ratio (OR) 5.89; 95% confidence interval (CI) 2.27-15.3; p < 0. 001) and a transplacental cordocentesis (OR 37.0; 95% CI 2.15-636; p < 0.001). The volume of FMH was greater after cordocentesis with an anterior placenta (90th percentile 6.20 ml) than after cordocentesis with a lateral (90th percentile 4.58 ml) or posterior placenta (90th percentile 1.35 ml) (p < 0.001). After fetal blood sampling, significant FMH occurred more frequently with a procedure duration of 3 min or more (OR 4.45; 95% CI 1.70-11.7; p = 0.002) and with two or more needle insertions (OR 4.65; 95% CI 1.80-12.1; p = 0.001). CONCLUSIONS FMH following cordocentesis may be related to placental injuries. This event is influenced by placental location, procedure duration and the number of needle insertions.

UI MeSH Term Description Entries
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D005260 Female Females
D005331 Fetomaternal Transfusion Transplacental passage of fetal blood into the circulation of the maternal organism. (Dorland, 27th ed) Hemorrhage, Fetomaternal,Fetomaternal Hemorrhage,Fetomaternal Hemorrhages,Fetomaternal Transfusions,Hemorrhages, Fetomaternal,Transfusion, Fetomaternal,Transfusions, Fetomaternal
D005865 Gestational Age The age of the conceptus, beginning from the time of FERTILIZATION. In clinical obstetrics, the gestational age is often estimated from the onset of the last MENSTRUATION which is about 2 weeks before OVULATION and fertilization. It is also estimated to begin from fertilization, estrus, coitus, or artificial insemination. Embryologic Age,Fetal Maturity, Chronologic,Chronologic Fetal Maturity,Fetal Age,Maturity, Chronologic Fetal,Age, Embryologic,Age, Fetal,Age, Gestational,Ages, Embryologic,Ages, Fetal,Ages, Gestational,Embryologic Ages,Fetal Ages,Gestational Ages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016017 Odds Ratio The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Cross-Product Ratio,Risk Ratio,Relative Odds,Cross Product Ratio,Cross-Product Ratios,Odds Ratios,Odds, Relative,Ratio, Cross-Product,Ratio, Risk,Ratios, Cross-Product,Ratios, Risk,Risk Ratios

Related Publications

Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
April 1992, Revue medicale de Bruxelles,
Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
August 1982, Archives of pathology & laboratory medicine,
Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
January 1990, Indian journal of pediatrics,
Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
April 2012, American journal of hematology,
Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
September 2011, Irish journal of medical science,
Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
December 1985, American journal of obstetrics and gynecology,
Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
May 1986, Southern medical journal,
Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
January 2001, Fetal diagnosis and therapy,
Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
April 1967, American journal of obstetrics and gynecology,
Y Chitrit, and P Caubel, and D Lusina, and M Boulanger, and F Balledent, and A L Schwinte, and R Herrero
July 2018, Cytometry. Part B, Clinical cytometry,
Copied contents to your clipboard!